// App-Quantinova.ai

FRI0148 : REMISSION RATES INCREASE SUBSTANTIALLY BY ADDING ADALIMUMAB TO METHOTREXATE AND INTRA-ARTICULAR GLUCOCORTICOID IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS - 1-YEAR RESULTS OF INVESTIGATOR-INITIATED, DOUBLE-BLINDED RANDOMIZED CLINICAL TRIAL (OPERA)

Researchers

Presenter

  • K. Horslev-Petersen

Principal Investigators

  • P. Junker

  • H.C. Horn

  • A. Jorgensen

  • S.B. Krintel

  • J. Raun

  • C.G. Ammitzboll

  • J.S. Johansen

  • M. Ostergaard

  • K. Stengaard-Pedersen

  • J. Podenphant

  • T. Ellingsen

  • P. Ahlquist

  • H. Lindegaard

  • A. Linauskas

  • A. Schlemmer

  • M.Y. Dam

  • I. Hansen

Medical Centers

  • Rheumatology, University, Aarhus, Denmark

Locations

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Rheumatoid arthritis

  • Gastric antral vascular ectasia

Biomarkers

  • anti-CCP antibodies

  • C reactive protein

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Triamcinolone acetonide

  • Methotrexate

  • Prednisolone

  • Adalimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved